J.w. Cole Advisors »

Iovance Biotherapeutics shares owned by J.w. Cole Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by J.w. Cole Advisors from 13F filings

Historical chart of J.w. Cole Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by J.w. Cole Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by J.w. Cole Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $157k 11k 14.82
2023-12-31 $506k 62k 8.13

More positions owned by J.w. Cole Advisors

Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds Growth Etf (VUG)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr S&p 500 Grwt Etf (IVW)
Select Sector Spdr Tr Technology (XLK)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for J.w. Cole Advisors

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
venBio Select Advisor
Geode Capital Management
T. Rowe Price Associates
Artisan Partners Limited Partnership
Susquehanna International
Jpmorgan Chase & Co
Goldman Sachs Group
Soleus Capital Management
Voloridge Investment Management
Pictet Asset Management Holding SA
Summit Partners Public Asset Management

View all funds holding Iovance Biotherapeutics